Cook Steven L. 4/A
4/A · Omada Health, Inc. · Filed Jul 8, 2026
Research Summary
AI-generated summary of this filing
Omada Health (OMDA) CFO Steven Cook Exercises Options & Sells Shares
What Happened
Steven L. Cook, Chief Financial Officer of Omada Health (OMDA), exercised a total of 2,900 option shares (2,600 on 6/24/2026 and 300 on 6/25/2026) at a $8.01 strike (total exercise cost reported $23,229) and sold those shares the same days for aggregate proceeds of approximately $55,146. The sales were reported as open-market disposals (weighted-average prices reported of ~$19.02 and $19.00). The filing is an amendment to the original Form 4 to add the omitted exercise entries; the corresponding sales were timely reported in the original filing.
Key Details
- Dates & prices:
- 2026-06-24: exercised 2,600 shares @ $8.01 (reported $20,826) and sold 2,600 shares @ $19.02 (reported $49,445; executed in multiple trades; weighted avg per F3/F4).
- 2026-06-25: exercised 300 shares @ $8.01 (reported $2,403) and sold 300 shares @ $19.00 (reported $5,701).
- Total: 2,900 options exercised for ~$23,229; total sale proceeds reported ~$55,146.
- Post-transaction holdings: the amended Form 4 states Box 5 (beneficial ownership) was adjusted to correct an understatement due to the omitted exercises — see the Form 4/A for the exact post-transaction figure.
- Footnotes: filing is an amendment to correct omitted exercise transactions (F1); the sale(s) were made pursuant to a 10b5-1 trading plan adopted March 14, 2026 (F2); sale executions were in multiple trades with weighted-average prices (F3/F4); option vesting is monthly from Feb 1, 2024, fully vested after four years (F5).
- Timeliness: the original Form 4 reported the sales timely; this Form 4/A restates the filing to add the previously omitted exercises.
Context
These were same-day exercise-and-sale transactions (often called cashless exercises): Cook exercised vested options and immediately sold the shares. Such transactions are typically routine liquidity events rather than direct endorsements of company prospects. The amendment simply corrects reporting to show the exercises that produced the sold shares; it does not change the fact that sales were previously disclosed.
Insider Transaction Report
- Exercise/Conversion
Common Stock
[F1]2026-06-24$8.01/sh+2,600$20,826→ 189,809 total - Sale
Common Stock
[F2][F3][F1]2026-06-24$19.02/sh−2,600$49,445→ 187,209 total - Exercise/Conversion
Common Stock
[F1]2026-06-25$8.01/sh+300$2,403→ 187,509 total - Sale
Common Stock
[F2][F4][F1]2026-06-25$19.00/sh−300$5,701→ 187,209 total - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F5]2026-06-24−2,600→ 40,561 totalExercise: $8.01Exp: 2034-02-08→ Common Stock (2,600 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
[F1][F5]2026-06-25−300→ 40,261 totalExercise: $8.01Exp: 2034-02-08→ Common Stock (300 underlying)
Footnotes (5)
- [F1]This Form 4/A restates in its entirety the original Form 4 filed on 6/26/2026 to report exercise transactions that were inadvertently omitted from the original filing. The exercises reported herein were part of same-day exercise-and-sale transactions, and the corresponding sales were timely reported in the original Form 4. Due to the omission of these exercise transactions, the amount of securities beneficially owned following the sales was understated. The amount of securities beneficially owned has been adjusted in Box 5 of Table I of this Form 4/A to correct the aforementioned error.
- [F2]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 14, 2026.
- [F3]This transaction was executed in multiple trades at prices ranging from $19.00 to $19.04. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F4]This transaction was executed in multiple trades at prices ranging from $19.00 to $19.01. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F5]1/48th of the shares subject to the option vest on each monthly anniversary measured from February 1, 2024 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date.